Skip to main content
. 2018 Nov 14;10(11):442. doi: 10.3390/cancers10110442

Figure 1.

Figure 1

Spectrum of the BRCA1/2 pathogenic variants identified in the studied cohort of 333 unselected ovarian cancer individuals. Each number in circle corresponds with the total number of individuals heterozygous for a specific variant. The figure was prepared using the ProteinPaint application (©Copyright 2015 St. Jude Children’s Research Hospital; 262 Danny Thomas Place, Memphis, TN 38105, USA) [16].